Skip to content
DefDex

Other

Illumina

ILMN

Genomics company offering DNA sequencing, array-based technology and multiomics solutions for life sciences, clinical medicine and therapeutic discovery.

Website

Portfolio1 company · 1 lead

  • Series B · Participant
    $200M
    Mar 1, 2018
  • Series A · Led the round
    $100M
    Aug 18, 2015

One row per round this investor joined. Round size is the whole round, not this investor's share.

Sources3

  1. 1

    Bio-IT World · Aug 18, 2015 · Supports Organization · amount

    “Helix--a new genomics analytics venture--is to launch today with $100 million in funding from Illumina, Warburg Pincus, and Sutter Hill Ventures”
  2. 2

    Illumina · Supports Organization · description

    “Our portfolio of DNA sequencing, array-based technology, and multiomics solutions fuels advancements across life sciences, clinical medicine, and therapeutic discovery.”
  3. 3

    U.S. Securities and Exchange Commission · Supports Organization · ownership

    “[1110803,"ILLUMINA, INC.","ILMN","Nasdaq"]”

Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.